In today's Pharma Pulse, the NCPA warns of a severe cash flow crisis for independent pharmacies under the Medicare Drug Price ...

Key Takeaways. Section 804 creates a legal pathway for states and tribes to import certain Canadian prescription drugs, contingent on demonstrable consumer savings and adherence t ...

In today’s Pharma Pulse, Eli Lilly has launched the Employer Connect platform broadening access to Zepbound for U.S. workers, ...

In today’s Pharma Pulse, Antengene and UCB ink a $1.18 billion global deal for ATG-201 to target autoimmune diseases, while ...

Thermal testing can make or break cold chain performance. Join this webinar to learn proven best practices that help eliminate blind spots, validate designs, and protect temperature-sensitive ...

A conversation with Kenco’s Tim McClatchy explores how pharmaceutical logistics providers are strengthening cybersecurity ...

How personalized interventions can help boost the omnichannel experience for patient hubs—and drive engagement and impact adherence in outcomes. Patient hubs are the backbone of any pharmacutical ...

The Inflation Reduction Act (IRA) of 2022 introduced sweeping changes to the US prescription drug market, most notably empowering Medicare to negotiate prices on high-cost medications, capping ...

FDA authorized Tec-Dara for RRMM after ≥1 prior line (PI + IMiD exposure), accelerating earlier-line use where attrition and refractoriness erode response with successive regimens. A 55-day review ...

In today's Pharma Pulse, the FDA expands the pediatric indication for Juxtapid to treat rare homozygous familial hypercholesterolemia, while Novo Nordisk announces a major €432 million investment in ...